Equities

Calmer Co International Ltd

Calmer Co International Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.01
  • Today's Change0.00 / 0.00%
  • Shares traded2.09m
  • 1 Year change+118.34%
  • Beta1.8323
Data delayed at least 20 minutes, as of Sep 20 2024 06:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Calmer Co International Ltd grew revenues 138.92% from 1.78m to 4.26m while net income improved from a loss of 5.24m to a smaller loss of 3.73m.
Gross margin49.62%
Net profit margin-87.42%
Operating margin-51.90%
Return on assets-98.45%
Return on equity--
Return on investment-395.42%
More ▼

Cash flow in AUDView more

In 2024, Calmer Co International Ltd increased its cash reserves by 137.81%, or 636.87k. Cash Flow from Financing totalled 2.83m or 66.39% of revenues. In addition the company used 2.08m for operations while cash used for investing totalled 116.97k.
Cash flow per share-0.0031
Price/Cash flow per share--
Book value per share-0.0003
Tangible book value per share-0.0006
More ▼

Balance sheet in AUDView more

Calmer Co International Ltd has a Debt to Total Capital ratio of 126.74%.
Current ratio0.9452
Quick ratio0.5607
Total debt/total equity--
Total debt/total capital1.27
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.